{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:36:57Z","timestamp":1794623817822,"version":"4.9.1"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glutamine: fructose-6-phosphate amidotransferase (GFAT), a conserved enzyme across prokaryotic and eukaryotic species, is the first and rate-limiting step in the hexosamine biosynthetic pathway (HBP), diverting 2\u20135% of fructose-6-phosphate derived from glucose toward the synthesis of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), a key substrate for the glycosylation of proteins and lipids. While substantial progress has been made in elucidating the basic biochemical properties and regulatory mechanisms of GFAT, its functional impact on pathological processes remains incompletely understood. Emerging evidence implicates GFAT in a spectrum of human diseases, including cancer, diabetes, cardiovascular disorders, and neurodegenerative conditions such as Alzheimer\u2019s disease. This review aims to provide a comprehensive synthesis of current insights into GFAT\u2019s role in disease etiology, with the goal of informing future research and therapeutic strategies targeting this essential metabolic regulator.<\/jats:p>","DOI":"10.1038\/s41420-025-02898-8","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:33:36Z","timestamp":1765668816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Glutamine: fructose-6-phosphate amidotransferase (GFAT) in the pathology of diseases: a review"],"prefix":"10.1038","volume":"12","author":[{"given":"Caiting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7582-8556","authenticated-orcid":false,"given":"Fengyu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3916-4182","authenticated-orcid":false,"given":"Huiping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-2424","authenticated-orcid":false,"given":"Miaomiao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-9820","authenticated-orcid":false,"given":"Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"2898_CR1","doi-asserted-by":"publisher","first-page":"25208","DOI":"10.1016\/S0021-9258(19)74026-5","volume":"267","author":"GL McKnight","year":"1992","unstructured":"McKnight GL, Mudri SL, Mathewes SL, Traxinger RR, Marshall S, Sheppard PO, et al. Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase. J Biol Chem. 1992;267:25208\u201312.","journal-title":"J Biol Chem"},{"key":"2898_CR2","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1016\/S0021-9258(19)67706-9","volume":"266","author":"S Marshall","year":"1991","unstructured":"Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 1991;266:4706\u201312.","journal-title":"J Biol Chem"},{"key":"2898_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100964","volume":"79","author":"A Magalh\u00e3es","year":"2021","unstructured":"Magalh\u00e3es A, Duarte HO, Reis CA. The role of O-glycosylation in human disease. Mol Aspects Med. 2021;79:100964.","journal-title":"Mol Aspects Med"},{"key":"2898_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-019-0671-3","volume":"17","author":"NM Akella","year":"2019","unstructured":"Akella NM, Ciraku L, Reginato MJ. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer. BMC Biology. 2019;17:52.","journal-title":"BMC Biology"},{"key":"2898_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","volume":"15","author":"C Reily","year":"2019","unstructured":"Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15:346\u201366.","journal-title":"Nat Rev Nephrol"},{"key":"2898_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep27278","volume":"6","author":"C Chaveroux","year":"2016","unstructured":"Chaveroux C, Sarcinelli C, Barbet V, Belfeki S, Barthelaix A, Ferraro-Peyret C, et al. Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway. Sci Rep. 2016;6:27278.","journal-title":"Sci Rep"},{"key":"2898_CR7","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1074\/jbc.AW119.003226","volume":"294","author":"GW Hart","year":"2019","unstructured":"Hart GW. Nutrient regulation of signaling and transcription. J Biol Chem. 2019;294:2211\u201331.","journal-title":"J Biol Chem"},{"key":"2898_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nrm3334","volume":"13","author":"JA Hanover","year":"2012","unstructured":"Hanover JA, Krause MW, Love DC. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol. 2012;13:312\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2898_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/10409238.2014.884535","volume":"49","author":"K Vaidyanathan","year":"2014","unstructured":"Vaidyanathan K, Durning S, Wells L. Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology. Crit Rev Biochem Mol Biol. 2014;49:140\u201363.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2898_CR10","doi-asserted-by":"crossref","unstructured":"Paneque A, Fortus H, Zheng J, Werlen G, Jacinto E. The Hexosamine Biosynthesis Pathway: Regulation and Function. Genes (Basel). 2023;14:933.","DOI":"10.3390\/genes14040933"},{"key":"2898_CR11","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.cell.2014.01.061","volume":"156","author":"MS Denzel","year":"2014","unstructured":"Denzel MS, Storm NJ, Gutschmidt A, Baddi R, Hinze Y, Jarosch E, et al. Hexosamine pathway metabolites enhance protein quality control and prolong life. Cell. 2014;156:1167\u201378.","journal-title":"Cell"},{"key":"2898_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100887","volume":"23","author":"M Horn","year":"2020","unstructured":"Horn M, Denzel SI, Srinivasan B, Allmeroth K, Schiffer I, Karthikaisamy V, et al. Hexosamine Pathway Activation Improves Protein Homeostasis through the Integrated Stress Response. iScience. 2020;23:100887.","journal-title":"iScience"},{"key":"2898_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14524-5","volume":"11","author":"S Ruegenberg","year":"2020","unstructured":"Ruegenberg S, Horn M, Pichlo C, Allmeroth K, Baumann U, Denzel MS. Loss of GFAT-1 feedback regulation activates the hexosamine pathway that modulates protein homeostasis. Nat Commun. 2020;11:687.","journal-title":"Nat Commun"},{"key":"2898_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.010","volume":"503","author":"C Lam","year":"2021","unstructured":"Lam C, Low J-Y, Tran PT, Wang H. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies. Cancer Lett. 2021;503:11\u20138.","journal-title":"Cancer Lett"},{"key":"2898_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24301-7","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu X, Bla\u017eenovi\u0107 I, Contreras AJ, Pham TM, Tabuloc CA, Li YH, et al. Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation. Nat Commun. 2021;12:4173.","journal-title":"Nat Commun"},{"key":"2898_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0021-9258(18)69397-4","volume":"235","author":"S Ghosh","year":"1960","unstructured":"Ghosh S, Blumenthal HJ, Davidson E, Roseman S. Glucosamine metabolism. V. Enzymatic synthesis of glucosamine 6-phosphate. J Biol Chem. 1960;235:1265\u201373.","journal-title":"J Biol Chem"},{"key":"2898_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0167-4838(02)00318-7","volume":"1597","author":"S Milewski","year":"2002","unstructured":"Milewski S. Glucosamine-6-phosphate synthase\u2013the multi-facets enzyme. Biochim Biophys Acta. 2002;1597:173\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"2898_CR18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0969-2126(98)00105-1","volume":"6","author":"A Teplyakov","year":"1998","unstructured":"Teplyakov A, Obmolova G, Badet-Denisot MA, Badet B, Polikarpov I. Involvement of the C terminus in intramolecular nitrogen channeling in glucosamine 6-phosphate synthase: evidence from a 1.6 A crystal structure of the isomerase domain. Structure. 1998;6:1047\u201355.","journal-title":"Structure"},{"key":"2898_CR19","doi-asserted-by":"publisher","first-page":"4404","DOI":"10.1074\/jbc.M511689200","volume":"281","author":"S Mouilleron","year":"2006","unstructured":"Mouilleron S, Badet-Denisot M-A, Golinelli-Pimpaneau B. Glutamine binding opens the ammonia channel and activates glucosamine-6P synthase. J Biol Chem. 2006;281:4404\u201312.","journal-title":"J Biol Chem"},{"key":"2898_CR20","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.febslet.2007.05.068","volume":"581","author":"N Floquet","year":"2007","unstructured":"Floquet N, Mouilleron S, Daher R, Maigret B, Badet B, Badet-Denisot M-A. Ammonia channeling in bacterial glucosamine-6-phosphate synthase (Glms): molecular dynamics simulations and kinetic studies of protein mutants. FEBS Lett. 2007;581:2981\u20137.","journal-title":"FEBS Lett"},{"key":"2898_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jmb.2007.07.002","volume":"372","author":"J Raczynska","year":"2007","unstructured":"Raczynska J, Olchowy J, Konariev PV, Svergun DI, Milewski S, Rypniewski W. The crystal and solution studies of glucosamine-6-phosphate synthase from Candida albicans. J Mol Biol. 2007;372:672\u201388.","journal-title":"J Mol Biol"},{"key":"2898_CR22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015189","volume":"296","author":"IA Oliveira","year":"2021","unstructured":"Oliveira IA, Allonso D, Fernandes TVA, Lucena DMS, Ventura GT, Dias WB, et al. Enzymatic and structural properties of human glutamine:fructose-6-phosphate amidotransferase 2 (hGFAT2). J Biol Chem. 2021;296:100180.","journal-title":"J Biol Chem"},{"key":"2898_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pep.2007.01.015","volume":"54","author":"C Richez","year":"2007","unstructured":"Richez C, Boetzel J, Floquet N, Koteshwar K, Stevens J, Badet B, et al. Expression and purification of active human internal His(6)-tagged L-glutamine: D-Fructose-6P amidotransferase I. Protein Expr Purif. 2007;54:45\u201353.","journal-title":"Protein Expr Purif"},{"key":"2898_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/geno.1999.5785","volume":"57","author":"T Oki","year":"1999","unstructured":"Oki T, Yamazaki K, Kuromitsu J, Okada M, Tanaka I. cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse. Genomics. 1999;57:227\u201334.","journal-title":"Genomics"},{"key":"2898_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbrc.2021.10.056","volume":"583","author":"AA Nabeebaccus","year":"2021","unstructured":"Nabeebaccus AA, Verma S, Zoccarato A, Emanuelli G, Santos CX, Streckfuss-B\u00f6meke K, et al. Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2. Biochem Biophys Res Commun. 2021;583:121\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2898_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/19336934.2020.1784674","volume":"14","author":"P Chen","year":"2020","unstructured":"Chen P, Visokay S, Abrams JM. Drosophila GFAT1 and GFAT2 enzymes encode obligate developmental functions. Fly (Austin). 2020;14:3\u20139.","journal-title":"Fly (Austin)"},{"key":"2898_CR27","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1016\/S0021-9258(18)95943-0","volume":"242","author":"R Kornfeld","year":"1967","unstructured":"Kornfeld R. Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J Biol Chem. 1967;242:3135\u201341.","journal-title":"J Biol Chem"},{"key":"2898_CR28","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1074\/jbc.M201056200","volume":"277","author":"KO Broschat","year":"2002","unstructured":"Broschat KO, Gorka C, Page JD, Martin-Berger CL, Davies MS, Huang Hc H-c, et al. Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: potent feedback inhibition by glucosamine 6-phosphate. J Biol Chem. 2002;277:14764\u201370.","journal-title":"J Biol Chem"},{"key":"2898_CR29","doi-asserted-by":"publisher","first-page":"13163","DOI":"10.1021\/bi700694c","volume":"46","author":"Y Li","year":"2007","unstructured":"Li Y, Roux C, Lazereg S, LeCaer J-P, Lapr\u00e9vote O, Badet B, et al. Identification of a novel serine phosphorylation site in human glutamine:fructose-6-phosphate amidotransferase isoform 1. Biochemistry. 2007;46:13163\u20139.","journal-title":"Biochemistry"},{"key":"2898_CR30","doi-asserted-by":"publisher","first-page":"16464","DOI":"10.1074\/jbc.RA118.003991","volume":"293","author":"JG Moloughney","year":"2018","unstructured":"Moloughney JG, Vega-Cotto NM, Liu S, Patel C, Kim PK, Wu C-C, et al. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation. J Biol Chem. 2018;293:16464\u201378.","journal-title":"J Biol Chem"},{"key":"2898_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2443.2008.01260.x","volume":"14","author":"S Eguchi","year":"2009","unstructured":"Eguchi S, Oshiro N, Miyamoto T, Yoshino K-I, Okamoto S, Ono T, et al. AMP-activated protein kinase phosphorylates glutamine: fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity. Genes Cells. 2009;14:179\u201389.","journal-title":"Genes Cells"},{"key":"2898_CR32","doi-asserted-by":"crossref","unstructured":"Campbell S, Mesaros C, Izzo L, Affronti H, Noji M, Schaffer BE, et al. Glutamine deprivation triggers NAGK-dependent hexosamine salvage. Elife. 2021;10:e62644.","DOI":"10.7554\/eLife.62644"},{"key":"2898_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"2898_CR34","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cac2.12374","volume":"42","author":"T Ge","year":"2022","unstructured":"Ge T, Gu X, Jia R, Ge S, Chai P, Zhuang A, et al. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Commun (Lond). 2022;42:1049\u201382.","journal-title":"Cancer Commun (Lond)"},{"key":"2898_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"2898_CR36","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"2898_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/srep39044","volume":"6","author":"C Yang","year":"2016","unstructured":"Yang C, Peng P, Li L, Shao M, Zhao J, Wang L, et al. High expression of GFAT1 predicts poor prognosis in patients with pancreatic cancer. Sci Rep. 2016;6:39044.","journal-title":"Sci Rep"},{"key":"2898_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1921609","volume":"2020","author":"C Jia","year":"2020","unstructured":"Jia C, Li H, Fu D, Lan Y. GFAT1\/HBP\/O-GlcNAcylation Axis Regulates \u03b2-Catenin Activity to Promote Pancreatic Cancer Aggressiveness. Biomed Res Int. 2020;2020:1921609.","journal-title":"Biomed Res Int"},{"key":"2898_CR39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2018.05.041","volume":"501","author":"K Ishino","year":"2018","unstructured":"Ishino K, Kudo M, Peng W-X, Kure S, Kawahara K, Teduka K, et al. 2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells. Biochem Biophys Res Commun. 2018;501:668\u201373.","journal-title":"Biochem Biophys Res Commun"},{"key":"2898_CR40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.21037\/atm-22-1946","volume":"10","author":"Z Wang","year":"2022","unstructured":"Wang Z, Kuang T, Wu W, Wang D, Lou W, Jin D, et al. GFAT1 is highly expressed in cancer stem cells of pancreatic cancer. Ann Transl Med. 2022;10:544.","journal-title":"Ann Transl Med"},{"key":"2898_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188409","volume":"1875","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, et al. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer. 2021;1875:188409.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2898_CR42","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019;156:2024\u201340.","journal-title":"Gastroenterology"},{"key":"2898_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1172\/JCI127515","volume":"130","author":"NS Sharma","year":"2020","unstructured":"Sharma NS, Gupta VK, Garrido VT, Hadad R, Durden BC, Kesh K, et al. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. J Clin Invest. 2020;130:451\u201365.","journal-title":"J Clin Invest"},{"key":"2898_CR44","doi-asserted-by":"crossref","unstructured":"Kim PK, Halbrook CJ, Kerk SA, Radyk M, Wisner S, Kremer DM, et al. Hyaluronic acid fuels pancreatic cancer cell growth. Elife. 2021;10:e62645.","DOI":"10.7554\/eLife.62645"},{"key":"2898_CR45","first-page":"1556","volume":"12","author":"Y-S Hsu","year":"2022","unstructured":"Hsu Y-S, Wu P-J, Jeng Y-M, Hu C-M, Lee W-H. Differential effects of glucose and N-acetylglucosamine on genome instability. Am J Cancer Res. 2022;12:1556\u201376.","journal-title":"Am J Cancer Res"},{"key":"2898_CR46","doi-asserted-by":"crossref","unstructured":"Pennell NA, Arcila ME, Gandara DR, West H. Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices. Am Soc Clin Oncol Educ Book. 2019;39:531\u201342.","DOI":"10.1200\/EDBK_237863"},{"key":"2898_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92725-8","volume":"11","author":"JW Chen","year":"2021","unstructured":"Chen JW, Dhahbi J. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods. Sci Rep. 2021;11:13323.","journal-title":"Sci Rep"},{"key":"2898_CR48","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/mc.22992","volume":"58","author":"W Chen","year":"2019","unstructured":"Chen W, Do KC, Saxton B, Leng S, Filipczak P, Tessema M, et al. Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells. Mol Carcinog. 2019;58:1046\u201355.","journal-title":"Mol Carcinog"},{"key":"2898_CR49","doi-asserted-by":"crossref","unstructured":"Dragic H, Barthelaix A, Duret C, Le Goupil S, Laprade H, Martin S, et al. The hexosamine pathway and coat complex II promote malignant adaptation to nutrient scarcity. Life Sci Alliance. 2022;5:e202101334.","DOI":"10.26508\/lsa.202101334"},{"key":"2898_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41421-022-00423-0","volume":"8","author":"S Wei","year":"2022","unstructured":"Wei S, Zhao Q, Zheng K, Liu P, Sha N, Li Y, et al. GFAT1-linked TAB1 glutamylation sustains p38 MAPK activation and promotes lung cancer cell survival under glucose starvation. Cell Discov. 2022;8:77.","journal-title":"Cell Discov"},{"key":"2898_CR51","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/carcin\/bgae005","volume":"45","author":"S Wei","year":"2024","unstructured":"Wei S, Ai M, Zhan Y, Yu J, Xie T, Hu Q, et al. TRIM14 suppressed the progression of NSCLC via hexosamine biosynthesis pathway. Carcinogenesis. 2024;45:324\u201336.","journal-title":"Carcinogenesis"},{"key":"2898_CR52","doi-asserted-by":"publisher","first-page":"e60471","DOI":"10.1371\/journal.pone.0060471","volume":"8","author":"F Alisson-Silva","year":"2013","unstructured":"Alisson-Silva F, Freire-de-Lima L, Donadio JL, Lucena MC, Penha L, S\u00e1-Diniz JN, et al. Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells. PLoS One. 2013;8:e60471.","journal-title":"PLoS One"},{"key":"2898_CR53","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1172\/JCI94844","volume":"128","author":"K Taparra","year":"2018","unstructured":"Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya MA, Wang X, et al. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. J Clin Invest. 2018;128:4924\u201337.","journal-title":"J Clin Invest"},{"key":"2898_CR54","doi-asserted-by":"crossref","unstructured":"Wang D, Wu J, Wang D, Huang X, Zhang N, Shi Y. Cisplatin enhances protein O\u2011GlcNAcylation by altering the activity of OGT, OGA and AMPK in human non\u2011small cell lung cancer cells. Int J Oncol. 2021;58:27.","DOI":"10.3892\/ijo.2021.5207"},{"key":"2898_CR55","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/carcin\/bgab063","volume":"42","author":"W Chen","year":"2021","unstructured":"Chen W, Saxton B, Tessema M, Belinsky SA. Inhibition of GFAT1 in lung cancer cells destabilizes PD-L1 protein. Carcinogenesis. 2021;42:1171\u20138.","journal-title":"Carcinogenesis"},{"key":"2898_CR56","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s42255-020-00316-0","volume":"2","author":"J Kim","year":"2020","unstructured":"Kim J, Lee HM, Cai F, Ko B, Yang C, Lieu EL, et al. The hexosamine biosynthesis pathway is a targetable liability in KRAS\/LKB1 mutant lung cancer. Nat Metab. 2020;2:1401\u201312.","journal-title":"Nat Metab"},{"key":"2898_CR57","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397:1750\u201369.","journal-title":"Lancet"},{"key":"2898_CR58","doi-asserted-by":"publisher","first-page":"e2353331","DOI":"10.1001\/jamanetworkopen.2023.53331","volume":"7","author":"S Xu","year":"2024","unstructured":"Xu S, Murtagh S, Han Y, Wan F, Toriola AT. Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Netw Open. 2024;7:e2353331.","journal-title":"JAMA Netw Open"},{"key":"2898_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.matbio.2017.12.015","volume":"67","author":"S Oikari","year":"2018","unstructured":"Oikari S, Kettunen T, Tiainen S, H\u00e4yrinen J, Masarwah A, Sudah M, et al. UDP-sugar accumulation drives hyaluronan synthesis in breast cancer. Matrix Biol. 2018;67:63\u201374.","journal-title":"Matrix Biol"},{"key":"2898_CR60","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1007\/s13277-015-4729-8","volume":"37","author":"T Dong","year":"2016","unstructured":"Dong T, Kang X, Liu Z, Zhao S, Ma W, Xuan Q, et al. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer. Tumour Biol. 2016;37:8159\u201368.","journal-title":"Tumour Biol"},{"key":"2898_CR61","doi-asserted-by":"publisher","first-page":"24105","DOI":"10.1074\/jbc.M116.751263","volume":"291","author":"T Chanmee","year":"2016","unstructured":"Chanmee T, Ontong P, Izumikawa T, Higashide M, Mochizuki N, Chokchaitaweesuk C, et al. Hyaluronan Production Regulates Metabolic and Cancer Stem-like Properties of Breast Cancer Cells via Hexosamine Biosynthetic Pathway-coupled HIF-1 Signaling. J Biol Chem. 2016;291:24105\u201320.","journal-title":"J Biol Chem"},{"key":"2898_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2034-y","volume":"10","author":"C Chokchaitaweesuk","year":"2019","unstructured":"Chokchaitaweesuk C, Kobayashi T, Izumikawa T, Itano N. Enhanced hexosamine metabolism drives metabolic and signaling networks involving hyaluronan production and O-GlcNAcylation to exacerbate breast cancer. Cell Death Dis. 2019;10:803.","journal-title":"Cell Death Dis"},{"key":"2898_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06900-6","volume":"15","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zhu T, Yu K, Shi M, Wang X, Wang L, et al. Correction to: Elevation of O-GlcNAc and GFAT expression by nicotine exposure promotes epithelial-mesenchymal transition and invasion in breast cancer cells. Cell Death Dis. 2024;15:612.","journal-title":"Cell Death Dis"},{"key":"2898_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.humpath.2018.03.011","volume":"76","author":"Q-S Ding","year":"2018","unstructured":"Ding Q-S, Zhang L, Wang B-C, Zeng Z, Zou X-Q, Cao P-B, et al. Aberrant high expression level of MORC2 is a common character in multiple cancers. Hum Pathol. 2018;76:58\u201367.","journal-title":"Hum Pathol"},{"key":"2898_CR65","first-page":"59","volume":"53","author":"Z Pan","year":"2018","unstructured":"Pan Z, Ding Q, Guo Q, Guo Y, Wu L, Wu L, et al. MORC2, a novel oncogene, is upregulated in liver cancer and contributes to proliferation, metastasis and chemoresistance. Int J Oncol. 2018;53:59\u201372.","journal-title":"Int J Oncol"},{"key":"2898_CR66","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41418-021-00901-0","volume":"29","author":"Y-Y Liu","year":"2022","unstructured":"Liu Y-Y, Liu H-Y, Yu T-J, Lu Q, Zhang F-L, Liu G-Y, et al. O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-\u03b2 signaling to breast cancer progression. Cell Death Differ. 2022;29:861\u201373.","journal-title":"Cell Death Differ"},{"key":"2898_CR67","doi-asserted-by":"crossref","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","DOI":"10.3322\/caac.21262"},{"key":"2898_CR68","doi-asserted-by":"publisher","first-page":"19205","DOI":"10.18632\/oncotarget.15164","volume":"8","author":"L Li","year":"2017","unstructured":"Li L, Shao M, Peng P, Yang C, Song S, Duan F, et al. High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 2017;8:19205\u201317.","journal-title":"Oncotarget"},{"key":"2898_CR69","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1021\/acs.biochem.9b00560","volume":"59","author":"LA Walter","year":"2020","unstructured":"Walter LA, Lin YH, Halbrook CJ, Chuh KN, He L, Pedowitz NJ, et al. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress. Biochemistry. 2020;59:3169\u201379.","journal-title":"Biochemistry"},{"key":"2898_CR70","doi-asserted-by":"crossref","unstructured":"Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, et al. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J Clin Invest. 2021;131:e144703.","DOI":"10.1172\/JCI144703"},{"key":"2898_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep08421","volume":"5","author":"H Li","year":"2015","unstructured":"Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, et al. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep. 2015;5:8421.","journal-title":"Sci Rep"},{"key":"2898_CR72","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature05660","volume":"445","author":"JY Lin","year":"2007","unstructured":"Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature. 2007;445:843\u201350.","journal-title":"Nature"},{"key":"2898_CR73","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1007\/s00018-016-2158-5","volume":"73","author":"AJ Deen","year":"2016","unstructured":"Deen AJ, Arasu UT, Pasonen-Sepp\u00e4nen S, Hassinen A, Takabe P, Wojciechowski S, et al. UDP-sugar substrates of HAS3 regulate its O-GlcNAcylation, intracellular traffic, extracellular shedding and correlate with melanoma progression. Cell Mol Life Sci. 2016;73:3183\u2013204.","journal-title":"Cell Mol Life Sci"},{"key":"2898_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101838","volume":"39","author":"J Jandova","year":"2021","unstructured":"Jandova J, Wondrak GT. Genomic GLO1 deletion modulates TXNIP expression, glucose metabolism, and redox homeostasis while accelerating human A375 malignant melanoma tumor growth. Redox Biol. 2021;39:101838.","journal-title":"Redox Biol"},{"key":"2898_CR75","doi-asserted-by":"crossref","unstructured":"Sobiepanek A, Milner-Krawczyk M, Musolf P, Starecki T, Kobiela T. Anandamide-Modulated Changes in Metabolism, Glycosylation Profile and Migration of Metastatic Melanoma Cells. Cancers (Basel). 2022;14:1419.","DOI":"10.3390\/cancers14061419"},{"key":"2898_CR76","doi-asserted-by":"publisher","first-page":"38427","DOI":"10.18632\/oncotarget.9538","volume":"7","author":"F Duan","year":"2016","unstructured":"Duan F, Jia D, Zhao J, Wu W, Min L, Song S, et al. Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer. Oncotarget. 2016;7:38427\u201339.","journal-title":"Oncotarget"},{"key":"2898_CR77","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10571-019-00659-7","volume":"39","author":"B Liu","year":"2019","unstructured":"Liu B, Huang Z-B, Chen X, See Y-X, Chen Z-K, Yao H-K. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1). Cell Mol Neurobiol. 2019;39:415\u201334.","journal-title":"Cell Mol Neurobiol"},{"key":"2898_CR78","doi-asserted-by":"publisher","first-page":"578","DOI":"10.7150\/thno.76614","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li J, Huang Y, Chen Y, Luo Z, Huang H, et al. Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1. Theranostics. 2023;13:578\u201395.","journal-title":"Theranostics"},{"key":"2898_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202993","volume":"9","author":"X Li","year":"2022","unstructured":"Li X, Peng X, Zhang C, Bai X, Li Y, Chen G, et al. Bladder Cancer-Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP-Related Metabolic Reprogramming and SerRS O-GlcNAcylation in Endothelial Cells. Adv Sci (Weinh). 2022;9:e2202993.","journal-title":"Adv Sci (Weinh)"},{"key":"2898_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.2","volume":"6","author":"A Vasconcelos-Dos-Santos","year":"2017","unstructured":"Vasconcelos-Dos-Santos A, Loponte HFBR, Mantuano NR, Oliveira IA, de Paula IF, Teixeira LK, et al. Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway. Oncogenesis. 2017;6:e306.","journal-title":"Oncogenesis"},{"key":"2898_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/srep43842","volume":"7","author":"C Phoomak","year":"2017","unstructured":"Phoomak C, Vaeteewoottacharn K, Silsirivanit A, Saengboonmee C, Seubwai W, Sawanyawisuth K, et al. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation. Sci Rep. 2017;7:43842.","journal-title":"Sci Rep"},{"key":"2898_CR82","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557\u201362.","journal-title":"JAMA"},{"key":"2898_CR83","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470\u20139.","journal-title":"Circulation"},{"key":"2898_CR84","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006;7:589\u2013600.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2898_CR85","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/FJC.0000000000000054","volume":"63","author":"ZV Wang","year":"2014","unstructured":"Wang ZV, Li DL, Hill JA. Heart failure and loss of metabolic control. J Cardiovasc Pharmacol. 2014;63:302\u201313.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2898_CR86","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/CIRCRESAHA.112.277392","volume":"111","author":"JC Chatham","year":"2012","unstructured":"Chatham JC, Young ME. Metabolic remodeling in the hypertrophic heart: fuel for thought. Circ Res. 2012;111:666\u20138.","journal-title":"Circ Res"},{"key":"2898_CR87","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","volume":"116","author":"H Ashrafian","year":"2007","unstructured":"Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116:434\u201348.","journal-title":"Circulation"},{"key":"2898_CR88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","volume":"123","author":"AA Gibb","year":"2018","unstructured":"Gibb AA, Hill BG. Metabolic Coordination of Physiological and Pathological Cardiac Remodeling. Circ Res. 2018;123:107\u201328.","journal-title":"Circ Res"},{"key":"2898_CR89","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012673","volume":"8","author":"DH Tran","year":"2019","unstructured":"Tran DH, Wang ZV. Glucose Metabolism in Cardiac Hypertrophy and Heart Failure. J Am Heart Assoc. 2019;8:e012673.","journal-title":"J Am Heart Assoc"},{"key":"2898_CR90","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurjhf\/hfr173","volume":"14","author":"H Ardehali","year":"2012","unstructured":"Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JGF, et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012;14:120\u20139.","journal-title":"Eur J Heart Fail"},{"key":"2898_CR91","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207\u201358.","journal-title":"Physiol Rev"},{"key":"2898_CR92","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1095-6433(03)00007-2","volume":"135","author":"HS Leong","year":"2003","unstructured":"Leong HS, Brownsey RW, Kulpa JE, Allard MF. Glycolysis and pyruvate oxidation in cardiac hypertrophy\u2013why so unbalanced? Comp Biochem Physiol A Mol Integr Physiol. 2003;135:499\u2013513.","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"2898_CR93","first-page":"251","volume":"1","author":"ME Young","year":"2007","unstructured":"Young ME, Yan J, Razeghi P, Cooksey RC, Guthrie PH, Stepkowski SM, et al. Proposed regulation of gene expression by glucose in rodent heart. Gene Regul Syst Bio. 2007;1:251\u201362.","journal-title":"Gene Regul Syst Bio"},{"key":"2898_CR94","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1152\/physiolgenomics.00016.2011","volume":"44","author":"IG Lunde","year":"2012","unstructured":"Lunde IG, Aronsen JM, Kval\u00f8y H, Qvigstad E, Sjaastad I, T\u00f8nnessen T, et al. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure. Physiol Genomics. 2012;44:162\u201372.","journal-title":"Physiol Genomics"},{"key":"2898_CR95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","volume":"123","author":"JH van Berlo","year":"2013","unstructured":"van Berlo JH, Maillet M, Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest. 2013;123:37\u201345.","journal-title":"J Clin Invest"},{"key":"2898_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15640-y","volume":"11","author":"DH Tran","year":"2020","unstructured":"Tran DH, May HI, Li Q, Luo X, Huang J, Zhang G, et al. Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling. Nat Commun. 2020;11:1771.","journal-title":"Nat Commun"},{"key":"2898_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103517","volume":"24","author":"A Ishikita","year":"2021","unstructured":"Ishikita A, Matsushima S, Ikeda S, Okabe K, Nishimura R, Tadokoro T, et al. GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway. iScience. 2021;24:103517.","journal-title":"iScience"},{"key":"2898_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02795-4","volume":"9","author":"R G\u00e9linas","year":"2018","unstructured":"G\u00e9linas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, et al. AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation. Nat Commun. 2018;9:374.","journal-title":"Nat Commun"},{"key":"2898_CR99","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14965","volume":"9","author":"WZ Zhu","year":"2021","unstructured":"Zhu WZ, Ledee D, Olson AK. Temporal regulation of protein O-GlcNAc levels during pressure-overload cardiac hypertrophy. Physiol Rep. 2021;9:e14965.","journal-title":"Physiol Rep"},{"key":"2898_CR100","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.yjmcc.2009.06.021","volume":"48","author":"L Maya","year":"2010","unstructured":"Maya L, Villarreal FJ. Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol. 2010;48:524\u20139.","journal-title":"J Mol Cell Cardiol"},{"key":"2898_CR101","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213\u201323.","journal-title":"Circulation"},{"key":"2898_CR102","doi-asserted-by":"publisher","first-page":"R689","DOI":"10.1152\/ajpregu.00548.2011","volume":"303","author":"ES Fricovsky","year":"2012","unstructured":"Fricovsky ES, Suarez J, Ihm S-H, Scott BT, Suarez-Ramirez JA, Banerjee I, et al. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol. 2012;303:R689\u2013R99.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2898_CR103","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphys.2020.00124","volume":"11","author":"MJ De Blasio","year":"2020","unstructured":"De Blasio MJ, Huynh N, Deo M, Dubrana LE, Walsh J, Willis A, et al. Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes. Front Physiol. 2020;11:124.","journal-title":"Front Physiol"},{"key":"2898_CR104","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","volume":"290","author":"MG Buse","year":"2006","unstructured":"Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab. 2006;290:E1\u2013E8.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2898_CR105","doi-asserted-by":"publisher","first-page":"44230","DOI":"10.1074\/jbc.M303810200","volume":"278","author":"RJ Clark","year":"2003","unstructured":"Clark RJ, McDonough PM, Swanson E, Trost SU, Suzuki M, Fukuda M, et al. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem. 2003;278:44230\u20137.","journal-title":"J Biol Chem"},{"key":"2898_CR106","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI117004","volume":"93","author":"FN Ziyadeh","year":"1994","unstructured":"Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest. 1994;93:536\u201342.","journal-title":"J Clin Invest"},{"key":"2898_CR107","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cvr\/cvs337","volume":"97","author":"RV Jensen","year":"2013","unstructured":"Jensen RV, Zachara NE, Nielsen PH, Kimose HH, Kristiansen SB, B\u00f8tker HE. Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. Cardiovasc Res. 2013;97:369\u201378.","journal-title":"Cardiovasc Res"},{"key":"2898_CR108","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2215\/CJN.00540705","volume":"1","author":"RE Gilbert","year":"2006","unstructured":"Gilbert RE, Connelly K, Kelly DJ, Pollock CA, Krum H. Heart failure and nephropathy: catastrophic and interrelated complications of diabetes. Clin J Am Soc Nephrol. 2006;1:193\u2013208.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2898_CR109","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature12537","volume":"502","author":"JR Erickson","year":"2013","unstructured":"Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature. 2013;502:372\u20136.","journal-title":"Nature"},{"key":"2898_CR110","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/cvr\/cvv136","volume":"107","author":"E Dubois-Deruy","year":"2015","unstructured":"Dubois-Deruy E, Belliard A, Mulder P, Bouvet M, Smet-Nocca C, Janel S, et al. Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failure. Cardiovasc Res. 2015;107:56\u201365.","journal-title":"Cardiovasc Res"},{"key":"2898_CR111","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/jcp.20609","volume":"207","author":"Y-H Kim","year":"2006","unstructured":"Kim Y-H, Song M, Oh Y-S, Heo K, Choi J-W, Park J-M, et al. Inhibition of phospholipase C-beta1-mediated signaling by O-GlcNAc modification. J Cell Physiol. 2006;207:689\u201396.","journal-title":"J Cell Physiol"},{"key":"2898_CR112","doi-asserted-by":"publisher","first-page":"39094","DOI":"10.1074\/jbc.M112.383778","volume":"287","author":"X Zhu-Mauldin","year":"2012","unstructured":"Zhu-Mauldin X, Marsh SA, Zou L, Marchase RB, Chatham JC. Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes. J Biol Chem. 2012;287:39094\u2013106.","journal-title":"J Biol Chem"},{"key":"2898_CR113","doi-asserted-by":"publisher","first-page":"C57","DOI":"10.1152\/ajpcell.00263.2005","volume":"290","author":"T Nagy","year":"2005","unstructured":"Nagy T, Champattanachai V, Marchase RB, Chatham JC. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. Am J Physiol Cell Physiol. 2005;290:C57\u2013C65.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2898_CR114","doi-asserted-by":"crossref","unstructured":"Chatham JC, Young ME, Zhang J. Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications. Curr Opin Pharmacol. 2021;57:1\u201312.","DOI":"10.1016\/j.coph.2020.08.005"},{"key":"2898_CR115","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1073\/pnas.94.12.6438","volume":"94","author":"MN Sack","year":"1997","unstructured":"Sack MN, Disch DL, Rockman HA, Kelly DP. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA. 1997;94:6438\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2898_CR116","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.111.031229","volume":"124","author":"J-S Hulot","year":"2011","unstructured":"Hulot J-S, Fauconnier J, Ramanujam D, Chaanine A, Aubart F, Sassi Y, et al. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation. 2011;124:796\u2013805.","journal-title":"Circulation"},{"key":"2898_CR117","doi-asserted-by":"publisher","first-page":"29665","DOI":"10.1074\/jbc.M114.578682","volume":"289","author":"S Muthusamy","year":"2014","unstructured":"Muthusamy S, DeMartino AM, Watson LJ, Brittian KR, Zafir A, Dassanayaka S, et al. MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression. J Biol Chem. 2014;289:29665\u201376.","journal-title":"J Biol Chem"},{"key":"2898_CR118","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/ki.1991.58","volume":"39","author":"JM Weinberg","year":"1991","unstructured":"Weinberg JM. The cell biology of ischemic renal injury. Kidney Int. 1991;39:476\u2013500.","journal-title":"Kidney Int"},{"key":"2898_CR119","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/00000441-199404000-00009","volume":"307","author":"BJ Zimmerman","year":"1994","unstructured":"Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci. 1994;307:284\u201392.","journal-title":"Am J Med Sci"},{"key":"2898_CR120","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0022-5347(01)66023-3","volume":"155","author":"DA Shoskes","year":"1996","unstructured":"Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol. 1996;155:1831\u201340.","journal-title":"J Urol"},{"key":"2898_CR121","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0002-9610(91)91120-8","volume":"161","author":"PM Reilly","year":"1991","unstructured":"Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg. 1991;161:488\u2013503.","journal-title":"Am J Surg"},{"key":"2898_CR122","first-page":"162","volume":"83","author":"SC Weight","year":"1996","unstructured":"Weight SC, Bell PR, Nicholson ML. Renal ischaemia\u2013reperfusion injury. Br J Surg. 1996;83:162\u201370.","journal-title":"Br J Surg"},{"key":"2898_CR123","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0955-470X(96)80016-4","volume":"10","author":"W Land","year":"1996","unstructured":"Land W, Messmer K, Events E. The Impact of Ischemia\/Reperfusion Injury on Specific and Non-Specific, Early and Late Chronic Events After Organ Transplantation. Transplantation Reviews. 1996;10:108\u201327.","journal-title":"Transplantation Reviews"},{"key":"2898_CR124","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev.ph.57.030195.001523","volume":"57","author":"DN Granger","year":"1995","unstructured":"Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol. 1995;57:311\u201332.","journal-title":"Annu Rev Physiol"},{"key":"2898_CR125","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2014.01.014","volume":"156","author":"ZV Wang","year":"2014","unstructured":"Wang ZV, Deng Y, Gao N, Pedrozo Z, Li DL, Morales CR, et al. Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway. Cell. 2014;156:1179\u201392.","journal-title":"Cell"},{"key":"2898_CR126","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.yjmcc.2006.09.015","volume":"42","author":"J Liu","year":"2007","unstructured":"Liu J, Marchase RB, Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia\/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol. 2007;42:177\u201385.","journal-title":"J Mol Cell Cardiol"},{"key":"2898_CR127","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1074\/jbc.M610965200","volume":"282","author":"P Raman","year":"2007","unstructured":"Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI. Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem. 2007;282:5704\u201314.","journal-title":"J Biol Chem"},{"key":"2898_CR128","doi-asserted-by":"publisher","first-page":"E499","DOI":"10.1152\/ajpendo.00507.2009","volume":"298","author":"AT Sage","year":"2010","unstructured":"Sage AT, Walter LA, Shi Y, Khan MI, Kaneto H, Capretta A, et al. Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation, and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metab. 2010;298:E499\u2013E511.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2898_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019.","journal-title":"Nat Rev Dis Primers"},{"key":"2898_CR130","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1021\/pr049849v","volume":"3","author":"K-C Chou","year":"2004","unstructured":"Chou K-C. Molecular therapeutic target for type-2 diabetes. J Proteome Res. 2004;3:1284\u20138.","journal-title":"J Proteome Res"},{"key":"2898_CR131","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1172\/JCI118876","volume":"98","author":"LF Hebert","year":"1996","unstructured":"Hebert LF, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest. 1996;98:930\u20136.","journal-title":"J Clin Invest"},{"key":"2898_CR132","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1016\/S0021-9258(18)99203-3","volume":"266","author":"S Marshall","year":"1991","unstructured":"Marshall S, Bacote V, Traxinger RR. Complete inhibition of glucose-induced desensitization of the glucose transport system by inhibitors of mRNA synthesis. Evidence for rapid turnover of glutamine:fructose-6-phosphate amidotransferase. J Biol Chem. 1991;266:10155\u201361.","journal-title":"J Biol Chem"},{"key":"2898_CR133","doi-asserted-by":"publisher","first-page":"23197","DOI":"10.1074\/jbc.271.38.23197","volume":"271","author":"MG Buse","year":"1996","unstructured":"Buse MG, Robinson KA, Marshall BA, Mueckler M. Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice. J Biol Chem. 1996;271:23197\u2013202.","journal-title":"J Biol Chem"},{"key":"2898_CR134","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1210\/en.2011-1295","volume":"152","author":"P Bhonagiri","year":"2011","unstructured":"Bhonagiri P, Pattar GR, Habegger KM, McCarthy AM, Tackett L, Elmendorf JS. Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance. Endocrinology. 2011;152:3373\u201384.","journal-title":"Endocrinology"},{"key":"2898_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101715","volume":"72","author":"JD Covert","year":"2023","unstructured":"Covert JD, Grice BA, Thornburg MG, Kaur M, Ryan AP, Tackett L, et al. An early, reversible cholesterolgenic etiology of diet-induced insulin resistance. Mol Metab. 2023;72:101715.","journal-title":"Mol Metab"},{"key":"2898_CR136","doi-asserted-by":"publisher","first-page":"31099","DOI":"10.1074\/jbc.M104115200","volume":"276","author":"H Kaneto","year":"2001","unstructured":"Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, et al. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem. 2001;276:31099\u2013104.","journal-title":"J Biol Chem"},{"key":"2898_CR137","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.2337\/db13-0312","volume":"62","author":"W Zhang","year":"2013","unstructured":"Zhang W, Liu J, Tian L, Liu Q, Fu Y, Garvey WT. TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway. Diabetes. 2013;62:4192\u2013200.","journal-title":"Diabetes"},{"key":"2898_CR138","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1385\/ENDO:23:1:17","volume":"23","author":"RR Bosch","year":"2004","unstructured":"Bosch RR, Pouwels M-JJM, Span PN, Olthaar AJ, Tack CJ, Hermus ARMM, et al. Hexosamines are unlikely to function as a nutrient-sensor in 3T3-L1 adipocytes: a comparison of UDP-hexosamine levels after increased glucose flux and glucosamine treatment. Endocrine. 2004;23:17\u201324.","journal-title":"Endocrine"},{"key":"2898_CR139","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977\u201386.","journal-title":"N Engl J Med"},{"key":"2898_CR140","doi-asserted-by":"crossref","unstructured":"Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev. 1992;8:85\u2013103.","DOI":"10.1002\/dmr.5610080202"},{"key":"2898_CR141","doi-asserted-by":"publisher","first-page":"15237","DOI":"10.1074\/jbc.271.25.15237","volume":"271","author":"PP Sayeski","year":"1996","unstructured":"Sayeski PP, Kudlow JE. Glucose Metabolism to Glucosamine Is Necessary for Glucose Stimulation of Transforming Growth Factor-\u03b1 Gene Transcription*. Journal of Biological Chemistry. 1996;271:15237\u201343.","journal-title":"Journal of Biological Chemistry"},{"key":"2898_CR142","first-page":"4596","volume":"10","author":"SG Mueller","year":"1990","unstructured":"Mueller SG, Paterson AJ, Kudlow JE. Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases. Mol Cell Biol. 1990;10:4596\u2013602.","journal-title":"Mol Cell Biol"},{"key":"2898_CR143","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/01.ATV.9.3.269","volume":"9","author":"M Klagsbrun","year":"1989","unstructured":"Klagsbrun M, Edelman ER. Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis. 1989;9:269\u201378.","journal-title":"Arteriosclerosis"},{"key":"2898_CR144","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/01.RES.68.1.106","volume":"68","author":"V Lindner","year":"1991","unstructured":"Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106\u201313.","journal-title":"Circ Res"},{"key":"2898_CR145","doi-asserted-by":"publisher","first-page":"15237","DOI":"10.1074\/jbc.271.25.15237","volume":"271","author":"PP Sayeski","year":"1996","unstructured":"Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem. 1996;271:15237\u201343.","journal-title":"J Biol Chem"},{"key":"2898_CR146","doi-asserted-by":"crossref","unstructured":"Dong W, Imdad L, Xu S, Wang Y, Liu C, Song S, et al. O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy. Int J Mol Sci. 2024;25:6286.","DOI":"10.3390\/ijms25116286"},{"key":"2898_CR147","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1016\/j.bbadis.2018.09.006","volume":"1864","author":"W Dai","year":"2018","unstructured":"Dai W, Dierschke SK, Toro AL, Dennis MD. Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3568\u201376.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2898_CR148","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Eshwaran R, Poschet G, Lomada S, Halawa M, Wilhelm K, et al. Involvement of NDPK-B in Glucose Metabolism-Mediated Endothelial Damage via Activation of the Hexosamine Biosynthesis Pathway and Suppression of O-GlcNAcase Activity. Cells. 2020;9:2324.","DOI":"10.3390\/cells9102324"},{"key":"2898_CR149","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/ndt\/gfg288","volume":"18","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Canaud B, Eckardt K-U, Stenvinkel P, Wanner C, Zoccali C. The importance of diabetic nephropathy in current nephrological practice. Nephrol Dial Transplant. 2003;18:1716\u201325.","journal-title":"Nephrol Dial Transplant"},{"key":"2898_CR150","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1046\/j.1523-1755.2000.07703.x","volume":"77","author":"ED Schleicher","year":"2000","unstructured":"Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int Suppl. 2000;77:S13\u2013S8.","journal-title":"Kidney Int Suppl"},{"key":"2898_CR151","doi-asserted-by":"publisher","first-page":"F151","DOI":"10.1152\/ajprenal.2001.281.1.F151","volume":"281","author":"LR James","year":"2001","unstructured":"James LR, Ingram A, Ly H, Thai K, Cai L, Scholey JW. Angiotensin II activates the GFAT promoter in mesangial cells. Am J Physiol Renal Physiol. 2001;281:F151\u2013F62.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2898_CR152","doi-asserted-by":"publisher","first-page":"15908","DOI":"10.1074\/jbc.M313524200","volume":"279","author":"C Weigert","year":"2004","unstructured":"Weigert C, Brodbeck K, Sawadogo M, H\u00e4ring HU, Schleicher ED. Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013\/-1002 in mesangial cells: up-regulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem. 2004;279:15908\u201315.","journal-title":"J Biol Chem"},{"key":"2898_CR153","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1172\/JCI119875","volume":"101","author":"V Kolm-Litty","year":"1998","unstructured":"Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest. 1998;101:160\u20139.","journal-title":"J Clin Invest"},{"key":"2898_CR154","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0014-5793(00)02395-4","volume":"488","author":"C Weigert","year":"2001","unstructured":"Weigert C, Brodbeck K, Lehmann R, H\u00e4ring HU, Schleicher ED. Overexpression of glutamine:fructose-6-phosphate-amidotransferase induces transforming growth factor-beta1 synthesis in NIH-3T3 fibroblasts. FEBS Lett. 2001;488:95\u20139.","journal-title":"FEBS Lett"},{"key":"2898_CR155","doi-asserted-by":"publisher","first-page":"F718","DOI":"10.1152\/ajprenal.2000.279.4.F718","volume":"279","author":"LR James","year":"2000","unstructured":"James LR, Fantus IG, Goldberg H, Ly H, Scholey JW. Overexpression of GFAT activates PAI-1 promoter in mesangial cells. Am J Physiol Renal Physiol. 2000;279:F718\u2013F27.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2898_CR156","doi-asserted-by":"publisher","first-page":"E210","DOI":"10.1152\/ajpendo.00232.2009","volume":"298","author":"LR James","year":"2010","unstructured":"James LR, Le C, Scholey JW. Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway flux. Am J Physiol Endocrinol Metab. 2010;298:E210\u2013E21.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2898_CR157","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2337\/diab.47.2.170","volume":"47","author":"AG Nerlich","year":"1998","unstructured":"Nerlich AG, Sauer U, Kolm-Litty V, Wagner E, Koch M, Schleicher ED. Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes. 1998;47:170\u20138.","journal-title":"Diabetes"},{"key":"2898_CR158","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jtcme.2016.11.007","volume":"7","author":"YS Jaiswal","year":"2016","unstructured":"Jaiswal YS, Tatke PA, Gabhe SY, Vaidya AB. Antidiabetic activity of extracts of Anacardium occidentale Linn. leaves on n-streptozotocin diabetic rats. J Tradit Complement Med. 2016;7:421\u20137.","journal-title":"J Tradit Complement Med"},{"key":"2898_CR159","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40203-021-00084-z","volume":"9","author":"VO Ukwenya","year":"2021","unstructured":"Ukwenya VO, Adelakun SA, Elekofehinti OO. Exploring the antidiabetic potential of compounds isolated from Anacardium occidentale using computational aproach: ligand-based virtual screening. In Silico Pharmacol. 2021;9:25.","journal-title":"In Silico Pharmacol"},{"key":"2898_CR160","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1002\/fsn3.3644","volume":"11","author":"H Gull","year":"2023","unstructured":"Gull H, Ikram A, Khalil AA, Ahmed Z, Nemat A. Assessing the multitargeted antidiabetic potential of three pomegranate peel-specific metabolites: An in silico and pharmacokinetics study. Food Sci Nutr. 2023;11:7188\u2013205.","journal-title":"Food Sci Nutr"},{"key":"2898_CR161","doi-asserted-by":"crossref","unstructured":"Ashraf SA, Elkhalifa AEO, Mehmood K, Adnan M, Khan MA, Eltoum NE, et al. Multi-Targeted Molecular Docking, Pharmacokinetics, and Drug-Likeness Evaluation of Okra-Derived Ligand Abscisic Acid Targeting Signaling Proteins Involved in the Development of Diabetes. Molecules. 2021;26:5957.","DOI":"10.3390\/molecules26195957"},{"key":"2898_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03632","volume":"6","author":"K Dami\u00e1n-Medina","year":"2020","unstructured":"Dami\u00e1n-Medina K, Salinas-Moreno Y, Milenkovic D, Figueroa-Y\u00e1\u00f1ez L, Marino-Marmolejo E, Higuera-Ciapara I, et al. In silico analysis of antidiabetic potential of phenolic compounds from blue corn (Zea mays L.) and black bean (Phaseolus vulgaris L.). Heliyon. 2020;6:e03632.","journal-title":"Heliyon"},{"key":"2898_CR163","first-page":"690","volume":"22","author":"H Derakhshanian","year":"2019","unstructured":"Derakhshanian H, Djalali M, Mohammad Hassan MH, Alvandi E, Eshraghian MR, Mirshafiey A, et al. Vitamin D suppresses cellular pathways of diabetes complication in liver. Iran J Basic Med Sci. 2019;22:690\u20134.","journal-title":"Iran J Basic Med Sci"},{"key":"2898_CR164","first-page":"217","volume":"7","author":"H Derakhshanian","year":"2019","unstructured":"Derakhshanian H, Djazayery A, Javanbakht MH, Eshraghian MR, Mirshafiey A, Zarei M, et al. The Effect of Vitamin D on Cellular Pathways of Diabetic Nephropathy. Rep Biochem Mol Biol. 2019;7:217\u201322.","journal-title":"Rep Biochem Mol Biol"},{"key":"2898_CR165","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1055\/s-2007-981469","volume":"115","author":"ZH Jia","year":"2007","unstructured":"Jia ZH, Liu ZH, Zheng JM, Zeng CH, Li LS. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db\/db mice. Exp Clin Endocrinol Diabetes. 2007;115:571\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2898_CR166","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/bjp.2008.26","volume":"153","author":"JM Zheng","year":"2008","unstructured":"Zheng JM, Zhu JM, Li LS, Liu ZH. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway. Br J Pharmacol. 2008;153:1456\u201364.","journal-title":"Br J Pharmacol"},{"key":"2898_CR167","doi-asserted-by":"crossref","unstructured":"Zuliani I, Lanzillotta C, Tramutola A, Barone E, Perluigi M, Rinaldo S, et al. High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer\u2019s Disease Signatures. Int J Mol Sci. 2021;22:3746.","DOI":"10.3390\/ijms22073746"},{"key":"2898_CR168","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1093\/brain\/awp099","volume":"132","author":"F Liu","year":"2009","unstructured":"Liu F, Shi J, Tanimukai H, Gu J, Gu J, Grundke-Iqbal I, et al. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer\u2019s disease. Brain. 2009;132:1820\u201332.","journal-title":"Brain"},{"key":"2898_CR169","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0092-8674(88)90015-3","volume":"55","author":"SP Jackson","year":"1988","unstructured":"Jackson SP, Tjian R. O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell. 1988;55:125\u201333.","journal-title":"Cell"},{"key":"2898_CR170","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0026-0495(98)90058-0","volume":"47","author":"H Yki-J\u00e4rvinen","year":"1998","unstructured":"Yki-J\u00e4rvinen H, Virkam\u00e4ki A, Daniels MC, McClain D, Gottschalk WK. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism. 1998;47:449\u201355.","journal-title":"Metabolism"},{"key":"2898_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113427","volume":"143","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Li X, Guo W, Huang Z. Enhancing GFPT1 expression with glutamine protects chondrocytes in osteoarthritis. Int Immunopharmacol. 2024;143:113427.","journal-title":"Int Immunopharmacol"},{"key":"2898_CR172","first-page":"27","volume":"3","author":"GS Kelly","year":"1998","unstructured":"Kelly GS. The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Altern Med Rev. 1998;3:27\u201339.","journal-title":"Altern Med Rev"},{"key":"2898_CR173","first-page":"75","volume":"44","author":"A Reichelt","year":"1994","unstructured":"Reichelt A, F\u00f6rster KK, Fischer M, Rovati LC, Setnikar I. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. Arzneimittelforschung. 1994;44:75\u201380.","journal-title":"Arzneimittelforschung"},{"key":"2898_CR174","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.joca.2003.11.002","volume":"12","author":"JN Gouze","year":"2004","unstructured":"Gouze JN, Gouze E, Palmer GD, Kaneto H, Ghivizzani SC, Grodzinsky AJ, et al. Adenovirus-mediated gene transfer of glutamine: fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1beta on rat chondrocytes. Osteoarthritis Cartilage. 2004;12:217\u201324.","journal-title":"Osteoarthritis Cartilage"},{"key":"2898_CR175","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4085\/1062-6050-51.5.08","volume":"52","author":"AC Thomas","year":"2017","unstructured":"Thomas AC, Hubbard-Turner T, Wikstrom EA, Palmieri-Smith RM. Epidemiology of Posttraumatic Osteoarthritis. Journal of Athletic Training. 2017;52:491\u20136.","journal-title":"Journal of Athletic Training"},{"key":"2898_CR176","doi-asserted-by":"crossref","unstructured":"Riegger J, Baumert J, Zaucke F, Brenner RE. The Hexosamine Biosynthetic Pathway as a Therapeutic Target after Cartilage Trauma: Modification of Chondrocyte Survival and Metabolism by Glucosamine Derivatives and PUGNAc in an Ex Vivo Model. Int J Mol Sci. 2021;22:7247.","DOI":"10.3390\/ijms22147247"},{"key":"2898_CR177","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s13105-023-00997-7","volume":"80","author":"S Jagannath","year":"2023","unstructured":"Jagannath S, Mallanna SH, Nandini CD. Diet-inducing hypercholesterolemia show decreased O-GlcNAcylation of liver proteins through modulation of AMPK. J Physiol Biochem. 2023;80:205\u201318.","journal-title":"J Physiol Biochem"},{"key":"2898_CR178","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.molcel.2016.07.015","volume":"63","author":"JG Moloughney","year":"2016","unstructured":"Moloughney JG, Kim PK, Vega-Cotto NM, Wu C-C, Zhang S, Adlam M, et al. mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1. Mol Cell. 2016;63:811\u201326.","journal-title":"Mol Cell"},{"key":"2898_CR179","doi-asserted-by":"crossref","unstructured":"Wu K, Chen L, Qiu Z, Zhao B, Hou J, Lei S, et al. Protective Effect and Mechanism of Xbp1s Regulating HBP\/O-GlcNAcylation through GFAT1 on Brain Injury after SAH. Biomedicines. 2023;11:1259.","DOI":"10.3390\/biomedicines11051259"},{"key":"2898_CR180","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jhep.2019.06.020","volume":"71","author":"B G\u00f6rg","year":"2019","unstructured":"G\u00f6rg B, Karababa A, Sch\u00fctz E, Paluschinski M, Schrimpf A, Shafigullina A, et al. O-GlcNAcylation-dependent upregulation of HO1 triggers ammonia-induced oxidative stress and senescence in hepatic encephalopathy. J Hepatol. 2019;71:930\u201341.","journal-title":"J Hepatol"},{"key":"2898_CR181","doi-asserted-by":"publisher","first-page":"12749","DOI":"10.1074\/jbc.RA118.001746","volume":"293","author":"RP Silva-Aguiar","year":"2018","unstructured":"Silva-Aguiar RP, Bezerra NCF, Lucena MC, Sirtoli GM, Sudo RT, Zapata-Sudo G, et al. O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats. J Biol Chem. 2018;293:12749\u201358.","journal-title":"J Biol Chem"},{"key":"2898_CR182","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1183\/09031936.00072709","volume":"35","author":"T Thenappan","year":"2010","unstructured":"Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J. 2010;35:1079\u201387.","journal-title":"Eur Respir J"},{"key":"2898_CR183","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","volume":"122","author":"RL Benza","year":"2010","unstructured":"Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010;122:164\u201372.","journal-title":"Circulation"},{"key":"2898_CR184","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1183\/09031936.00057010","volume":"36","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Ya\u00efci A, Montani D, O\u2019Callaghan DS, Ja\u00efs X, et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010;36:549\u201355.","journal-title":"Eur Respir J"},{"key":"2898_CR185","doi-asserted-by":"crossref","unstructured":"Prisco SZ, Rose L, Potus F, Tian L, Wu D, Hartweck L, et al. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. Int J Mol Sci. 2020;21:7278.","DOI":"10.3390\/ijms21197278"},{"key":"2898_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.627842","volume":"7","author":"S Bharadwaj","year":"2020","unstructured":"Bharadwaj S, Singh M, Kirtipal N, Kang SG. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells. Front Mol Biosci. 2020;7:627842.","journal-title":"Front Mol Biosci"},{"key":"2898_CR187","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1620\/tjem.196.65","volume":"196","author":"A Naganuma","year":"2002","unstructured":"Naganuma A, Furuchi T, Miura N, Hwang G-W, Kuge S. Investigation of intracellular factors involved in methylmercury toxicity. Tohoku J Exp Med. 2002;196:65\u201370.","journal-title":"Tohoku J Exp Med"},{"key":"2898_CR188","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0014-5793(99)01158-8","volume":"458","author":"N Miura","year":"1999","unstructured":"Miura N, Kaneko S, Hosoya S, Furuchi T, Miura K, Kuge S, et al. Overexpression of L-glutamine:D-fructose-6-phosphate amidotransferase provides resistance to methylmercury in Saccharomyces cerevisiae. FEBS Lett. 1999;458:215\u20138.","journal-title":"FEBS Lett"},{"key":"2898_CR189","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/1535-7163.MCT-18-0426","volume":"17","author":"A Asthana","year":"2018","unstructured":"Asthana A, Ramakrishnan P, Vicioso Y, Zhang K, Parameswaran R. Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death. Mol Cancer Ther. 2018;17:2226\u201337.","journal-title":"Mol Cancer Ther"},{"key":"2898_CR190","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s13311-021-01094-7","volume":"18","author":"S-M Kim","year":"2021","unstructured":"Kim S-M, Zhang S, Park J, Sung HJ, Tran T-DT, Chung C, et al. REM Sleep Deprivation Impairs Learning and Memory by Decreasing Brain O-GlcNAc Cycling in Mouse. Neurotherapeutics. 2021;18:2504\u201317.","journal-title":"Neurotherapeutics"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02898-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02898-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02898-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:02:42Z","timestamp":1769536962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02898-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":190,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2898"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02898-8","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}